Wang, X., Cao, X., Stinchcombe, T., Bradley, J., Adjei, A., Gandara, D. R., … Crawford, J. (2017). P2.03a-055 Predicting Risk of Chemotherapy-Induced Severe Neutropenia in Lung Patients: A Pooled Analysis of US Cooperative Group Trials. In Journal of Thoracic Oncology (Vol. 12, pp. S922–S923). Elsevier BV. https://doi.org/10.1016/j.jtho.2016.11.1265

Wang, Xiaofei, Xiaowen Cao, Thomas Stinchcombe, Jeffrey Bradley, Alex Adjei, David R. Gandara, Suresh Ramalingam, Herbert Pang, Everett Vokes, and Jeffrey Crawford. “P2.03a-055 Predicting Risk of Chemotherapy-Induced Severe Neutropenia in Lung Patients: A Pooled Analysis of US Cooperative Group Trials.” In Journal of Thoracic Oncology, 12:S922–23. Elsevier BV, 2017. https://doi.org/10.1016/j.jtho.2016.11.1265.

Wang X, Cao X, Stinchcombe T, Bradley J, Adjei A, Gandara DR, et al. P2.03a-055 Predicting Risk of Chemotherapy-Induced Severe Neutropenia in Lung Patients: A Pooled Analysis of US Cooperative Group Trials. In: Journal of Thoracic Oncology. Elsevier BV; 2017. p. S922–3.

Wang, Xiaofei, et al. “P2.03a-055 Predicting Risk of Chemotherapy-Induced Severe Neutropenia in Lung Patients: A Pooled Analysis of US Cooperative Group Trials.” Journal of Thoracic Oncology, vol. 12, no. 1, Elsevier BV, 2017, pp. S922–23. Crossref, doi:10.1016/j.jtho.2016.11.1265.

Wang X, Cao X, Stinchcombe T, Bradley J, Adjei A, Gandara DR, Ramalingam S, Pang H, Vokes E, Crawford J. P2.03a-055 Predicting Risk of Chemotherapy-Induced Severe Neutropenia in Lung Patients: A Pooled Analysis of US Cooperative Group Trials. Journal of Thoracic Oncology. Elsevier BV; 2017. p. S922–S923.